Pagenax is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (AMD) (see Pharmacology: Pharmacodynamics under Actions); visual impairment due to diabetic macular oedema (DME) (see Pharmacology: Pharmacodynamics under Actions).